Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms
Open accessAbstract
The impetus for discovery and evaluation of protein biomarkers has been accelerated by recent development of advanced technologies for rapid and broad proteome analyses. Mass spectrometry (MS)-based protein assays hold great potential for in vitro biomarker studies. Described here is the development of a multiplex mass spectrometric immunoassay (MSIA) for quantification of apolipoprotein C-I (apoC-I), apolipoprotein C-II (apoC-II), apolipoprotein C-III (apoC-III) and their proteoforms. The multiplex MSIA assay was fast (∼ 40 min) and high-throughput (96 samples at a time). The assay was applied to a small cohort of human plasma samples, revealing the existence of multiple proteoforms for each apolipoprotein C. The quantitative aspect of the assay enabled determination of the concentration for each proteoform individually. Low-abundance proteoforms, such as fucosylated apoC-III, were detected in less than 20% of the samples. The distribution of apoC-III proteoforms varied among samples with similar total apoC-III concentrations. The multiplex analysis of the three apolipoproteins C and their proteoforms using quantitative MSIA represents a significant step forward toward better understanding of their physiological roles in health and disease.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The des-TP apoC-I proteoform is present in human plasma at approximately 25% of the total apoC-I concentration.
“Trenchevska et al. reported that the des-TP apoC-I proteoform is present in human plasma at approximately 25% of the total apoC-I concentration (37) .”
From Automated multiplex LC-MS/MS assay for quantifying serum apolipoproteins A-I, B, C-I, C-II, C-III, and E with qualitative apolipoprotein E phenotyping (2016) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Loss-of-Function Mutations in <i>APOC3,</i> Triglycerides, and Coronary Disease
The TG and HDL Working Group of the Exome Sequencing Project, N. H. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1307095 · Cited by 1,071 · see citing works
Loss-of-Function Mutations in <i>APOC3</i> and Risk of Ischemic Vascular Disease
Jørgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308027 · Cited by 919 · see citing works
Graham, M. J., Lee, R. G., Bell, T. A., Fu, W., Mullick, A. E., Alexander, V. J., Singleton, W., Viney, N., Geary, R., Su, J., et al. (2013) · Circulation Research · doi:10.1161/circresaha.111.300367 · Cited by 377 · see citing works
Apolipoprotein C-III: Going Back to the Future for a Lipid Drug Target
Huff, M. W., & Hegele, R. A. (2013) · Circulation Research · doi:10.1161/circresaha.113.301464 · Cited by 70 · see citing works
Flagged first, then by citations
Research works printed but not linked: 50
- [1]Smith LM Kelleher NL C.f.T.D. Proteomics Nat Methods 2013 10 186 187 23443629 PMC4114032
- [2]Nelson RW Krone JR Bieber AL Williams P Anal Chem 1995 67 1153 1158 15134097
- [3]Nelson RW Borges CR J Am Soc Mass Spectrom 2011 22 960 968 21953037 PMC3761394
- [4]Issaq HJ Veenstra TD Conrads TP Felschow D Biochem Biophys Res Commun 2002 292 587 592 11922607
- [5]Anderson NL Anderson NG Haines LR Hardie DB Olafson RW Pearson TW J Proteome Res 2004 3 235 244 15113099
- [6]Razavi M Frick LE LaMarr WA Pope ME Miller CA Anderson NL Pearson TW J Proteome Res 2012 11 5642 5649 23126378
- [7]Reid JD Holmes DT Mason DR Shah B Borchers CH J Am Soc Mass Spectrom 2010 21 1680 1686 20199871
- [8]Mann M Nat Rev Mol Cell Biol 2006 7 952 958 17139335
- [9]Messana I Cabras T Iavarone F Vincenzoni F Urbani A Castagnola M J Sep Sci 2013 36 128 139 23212829
- [10]Weiß F van den Berg BH Planatscher H Pynn CJ Joos TO Poetz O Biochim Biophys Acta 2014 1844 927 932 24060810
- [11]Nedelkov D Tubbs KA Niederkofler EE Kiernan UA Nelson RW Anal. Chem 2004 76 1733 1737 15018576
- [12]Nedelkov D Kiernan UA Niederkofler EE Tubbs KA Nelson RW Proc Natl Acad Sci U S A 2005 102 10852 10857 16043703 PMC1180507
- [13]Nedelkov D Phillips DA Tubbs KA Nelson RW Mol Cell Proteomics 2007 6 1183 1187 17468123
- [14]Trenchevska O Phillips DA Nelson RW Nedelkov D PLoS One 2014 9 e100713 24955979 PMC4067327
- [15]Oran PE Trenchevska O Nedelkov D Borges CR Schaab MR Rehder DS Jarvis JW Sherma ND Shen L Krastins B Lopez MF Schwenke DC Reaven PD Nelson RW PLoS One 2014 9 e92801 24664114 PMC3963945
- [16]Niederkofler EE Phillips DA Krastins B Kulasingam V Kiernan UA Tubbs KA Peterman SM Prakash A Diamandis EP Lopez MF Nedelkov D PLoS One 2013 8 e81125 24278387 PMC3836743
- [17]Trenchevska O Kamcheva E Nedelkov D J Proteome Res 2010 9 5969 5973 20822186 PMC2976597
- [18]Trenchevska O Nedelkov D Proteome Sci 2011 9 19 21477312 PMC3080279
- [19]Trenchevska O Kamcheva E Nedelkov D Proteomics 2011 11 3633 3641 21751365 PMC4599786
- [20]Kiernan UA Phillips DA Trenchevska O Nedelkov D PLoS One 2011 6 e17282 21479165 PMC3068155
- [21]Sherma ND Borges CR Trenchevska O Jarvis JW Rehder DS Oran PE Nelson RW Nedelkov D Proteome Sci 2014 12 52 25328446 PMC4201675
- [22]Kiernan UA Nedelkov D Nelson RW J Proteome Res 2006 5 2928 2934 17081044
- [23]Kiernan UA Addobbati R Nedelkov D Nelson RW J Proteome Res 2006 5 1682 1687 16823976
- [24]Jong MC Hofker MH Havekes LM Arterioscler Thromb Vasc Biol 1999 19 472 484 10073946
- [25]Kei AA Filippatos TD Tsimihodimos V Elisaf MS Metabolism 2012 61 906 921 22304839
- [26]Zheng C Khoo C Furtado J Sacks FM Circulation 2010 121 1722 1734 20368524 PMC3153990
- [27]Hegele RA Connelly PW Hanley AJG Sun F Harris SB Zinman B Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 2753 2758 9409252
- [28]Jørgensen AB Frikke-Schmidt R Nordestgaard BG Tybjærg-Hansen A New England Journal of Medicine 2014 371 32 41 24941082
- [30]Huff MW Hegele RA Circ Res 2013 112 1405 1408 23704213
- [31]Graham MJ Lee RG Bell TA Fu W Mullick AE Alexander VJ Singleton W Viney N Geary R Su J Baker BF Burkey J Crooke ST Crooke RM Circ Res 2013 112 1479 1490 23542898
- [32]Bondarenko PV Cockrill SL Watkins LK Cruzado ID Macfarlane RD J Lipid Res 1999 40 543 555 10064743
- [33]Nicolardi S van der Burgt YE Wuhrer M Deelder AM Proteomics 2013 13 992 1001 23335445
- [34]Wada Y Kadoya M Okamoto N Glycobiology 2012 22 1140 1144 22611120
- [35]Flood-Nichols SK Tinnemore D Wingerd MA Abu-Alya AI Napolitano PG Stallings JD Ippolito DL Mol Cell Proteomics 2013 12 55 64 23059768 PMC3536909
- [36]Rezeli M Végvári Á Donnarumma F Gidlöf O Smith JG Erlinge D Marko-Varga G J Proteomics 2013 87 16 25 23707545
- [37]Jian W Edom RW Wang D Weng N Zhang SW Anal Chem 2013 85 2867 2874 23368640
- [38]Kingsmore SF Nat Rev Drug Discov 2006 5 310 320 16582876 PMC1780251
- [39]Peterman S Niederkofler EE Phillips DA Krastins B Kiernan UA Tubbs KA Nedelkov D Prakash A Vogelsang MS Schoeder T Couchman L Taylor DR Moniz CF Vadali G Byram G Lopez MF Proteomics 2014 14 1445 1456 24668948
- [40]Kuhn E Addona T Keshishian H Burgess M Mani DR Lee RT Sabatine MS Gerszten RE Carr SA Clin Chem 2009 55 1108 1117 19372185 PMC2865473
- [41]Keshishian H Addona T Burgess M Kuhn E Carr SA Mol Cell Proteomics 2007 6 2212 2229 17939991 PMC2435059
- [42]Chapman JD Goodlett DR Masselon CD Mass Spectrom Rev 2014 33 452 470 24281846
- [43]Augustyns K Bal G Thonus G Belyaev A Zhang XM Bollaert W Lambeir AM Durinx C Goossens F Haemers A Curr Med Chem 1999 6 311 327 10101215
- [44]Lambeir AM Durinx C Scharpé S De Meester I Crit Rev Clin Lab Sci 2003 40 209 294 12892317
- [45]Fojo SS Taam L Fairwell T Ronan R Bishop C Meng MS Hoeg JM Sprecher DL Brewer HB J Biol Chem 1986 261 9591 9594 3525527
- [46]Carr SA Abbatiello SE Ackermann BL Borchers C Domon B Deutsch EW Grant RP Hoofnagle AN Hüttenhain R Koomen JM Liebler DC Liu T MacLean B Mani DR Mansfield E Neubert H Paulovich AG Reiter L Vitek O Aebersold R Anderson L Bethem R Blonder J Boja E Botelho J Boyne M Bradshaw RA Burlingame AL Chan D Keshishian H Kuhn E Kinsinger C Lee JS Lee SW Moritz R Oses-Prieto J Rifai N Ritchie J Rodriguez H Srinivas PR Townsend RR Van Eyk J Whiteley G Wiita A Weintraub S Mol Cell Proteomics 2014 13 907 917 24443746 PMC3945918
- [47]Pratley RE Salsali A Curr Med Res Opin 2007 23 919 931 17407649
- [48]Barnett A Int J Clin Pract 2006 60 1454 1470 17073841
- [49]Goldberg IJ Scheraldi CA Yacoub LK Saxena U Bisgaier CL J Biol Chem 1990 265 4266 4272 2307668
- [50]Balog CI Mayboroda OA Wuhrer M Hokke CH Deelder AM Hensbergen PJ Mol Cell Proteomics 2010 9 667 681 20071361 PMC2860228
- [51]Nicolardi S van der Burgt YE Dragan I Hensbergen PJ Deelder AM J Proteome Res 2013 12 2260 2268 23527852
Cited by
Sorted by citations
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Borén, J., Packard, C. J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00474 · Cited by 196 · see citing works
Neubert, H., Shuford, C. M., Olah, T. V., Garofolo, F., Schultz, G. A., Jones, B. R., Amaravadi, L., Laterza, O. F., Xu, K., & Ackermann, B. L. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvz022 · Cited by 109 · see citing works
van den Broek, I., Romijn, F. P. H. T. M., Nouta, J., van der Laarse, A., Drijfhout, J. W., Smit, N. P. M., van der Burgt, Y. E. M., & Cobbaert, C. M. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.246702 · Cited by 105 · see citing works
Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia
Renee Ruhaak, L., van der Laarse, A., & Cobbaert, C. M. (2019) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563219827620 · Cited by 38 · see citing works
- Authors
- Trenchevska, O., Schaab, M. R., Nelson, R. W., & Nedelkov, D.
- Affiliations
- Arizona State University (US)
- Corresponding author
- Nedelkov, Dobrin
- Venue
- Methods
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 81
- Pages
- 86-92
- ISSN
- 1046-2023 (ISSN-L)
- PMC
- PMC4574700
- OpenAlex
- W2081058730
- Cited by
- 47
- References
- 4
- Citations by year
- 2026: 1 · 2024: 5 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 7 · 2016: 13 · 2015: 5
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Methods (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Arizona State University Library Digital Repository (Arizona State University) (acceptedVersion, cc-by-nc-nd)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082542, R24DK090958)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- apolipoprotein C-I, apolipoprotein C-II, apolipoprotein C-III, proteoforms, protein biomarkers, plasma apolipoproteins
- MeSH terms
- Humans, Immunoassay, Protein Processing, Post-Translational, Mass Spectrometry, Protein Isoforms, Apolipoprotein C-I, Apolipoprotein C-II, Apolipoprotein C-III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review